MTBP phosphorylation controls DNA replication origin firing.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 02 2021
Historique:
received: 23 08 2020
accepted: 28 01 2021
entrez: 20 2 2021
pubmed: 21 2 2021
medline: 15 12 2021
Statut: epublish

Résumé

Faithful genome duplication requires regulation of origin firing to determine loci, timing and efficiency of replisome generation. Established kinase targets for eukaryotic origin firing regulation are the Mcm2-7 helicase, Sld3/Treslin/TICRR and Sld2/RecQL4. We report that metazoan Sld7, MTBP (Mdm2 binding protein), is targeted by at least three kinase pathways. MTBP was phosphorylated at CDK consensus sites by cell cycle cyclin-dependent kinases (CDK) and Cdk8/19-cyclin C. Phospho-mimetic MTBP CDK site mutants, but not non-phosphorylatable mutants, promoted origin firing in human cells. MTBP was also phosphorylated at DNA damage checkpoint kinase consensus sites. Phospho-mimetic mutations at these sites inhibited MTBP's origin firing capability. Whilst expressing a non-phospho MTBP mutant was insufficient to relieve the suppression of origin firing upon DNA damage, the mutant induced a genome-wide increase of origin firing in unperturbed cells. Our work establishes MTBP as a regulation platform of metazoan origin firing.

Identifiants

pubmed: 33608586
doi: 10.1038/s41598-021-83287-w
pii: 10.1038/s41598-021-83287-w
pmc: PMC7895959
doi:

Substances chimiques

Carrier Proteins 0
DNA-Binding Proteins 0
MTBP protein, human 0
Cyclin-Dependent Kinases EC 2.7.11.22

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4242

Références

Genes Dev. 2015 Mar 1;29(5):555-66
pubmed: 25737283
Cell Rep. 2014 Sep 11;8(5):1583-94
pubmed: 25159151
Mol Cell Biol. 2000 May;20(9):3086-96
pubmed: 10757793
EMBO J. 2011 May 18;30(10):2019-30
pubmed: 21487389
Mol Cell. 2011 Mar 4;41(5):543-53
pubmed: 21362550
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15390-5
pubmed: 25313033
Cell Rep. 2014 Apr 10;7(1):62-9
pubmed: 24685139
Nat Methods. 2013 Jul;10(7):634-7
pubmed: 23749302
PLoS Biol. 2019 Jan 29;17(1):e2006767
pubmed: 30695077
Nature. 2018 Jul;559(7713):279-284
pubmed: 29950726
Mol Cell Proteomics. 2013 Mar;12(3):825-31
pubmed: 23266961
EMBO J. 2011 Nov 11;30(23):4805-14
pubmed: 22081107
Nature. 2010 Jan 7;463(7277):113-7
pubmed: 20054399
Nature. 2007 Jan 18;445(7125):281-5
pubmed: 17167417
Oncogene. 2010 Jun 3;29(22):3287-96
pubmed: 20305689
Sci Signal. 2011 Jun 28;4(179):rs5
pubmed: 21712546
Mol Cell Biol. 2005 Jan;25(2):545-53
pubmed: 15632057
EMBO J. 2001 Apr 17;20(8):2097-107
pubmed: 11296242
Nat Genet. 2007 Jan;39(1):93-8
pubmed: 17143284
Mol Cell. 2015 Mar 19;57(6):1124-1132
pubmed: 25752575
Nat Commun. 2017 Aug 8;8(1):206
pubmed: 28785014
J Biol Chem. 2000 Oct 13;275(41):31883-90
pubmed: 10906133
Curr Biol. 2011 Jul 12;21(13):1152-7
pubmed: 21700459
EMBO J. 2003 May 15;22(10):2526-35
pubmed: 12743046
Cold Spring Harb Perspect Biol. 2012 Oct 01;4(10):
pubmed: 22904560
Nature. 2007 Jan 18;445(7125):328-32
pubmed: 17167415
Nat Cell Biol. 2004 Jul;6(7):648-55
pubmed: 15220931
Nature. 2010 Sep 23;467(7314):474-8
pubmed: 20835227
Int J Mol Sci. 2018 Aug 13;19(8):
pubmed: 30104465
J Cell Biol. 2002 Nov 25;159(4):541-7
pubmed: 12438414
EMBO Rep. 2017 Oct;18(10):1752-1761
pubmed: 28818838
Mol Cell. 2006 Oct 6;24(1):101-13
pubmed: 17018296
J Biol Chem. 2011 Jan 28;286(4):2486-91
pubmed: 21098477
Genes Dev. 2014 Feb 15;28(4):372-83
pubmed: 24532715
Nature. 2015 Mar 26;519(7544):431-5
pubmed: 25739503
Mol Cell Proteomics. 2014 Jul;13(7):1690-704
pubmed: 24719451
Cancer Res. 2014 Jul 1;74(13):3591-602
pubmed: 24786788
Sci Adv. 2019 May 22;5(5):eaav3660
pubmed: 31131319
Mol Cell Proteomics. 2011 Oct;10(10):M111.013284
pubmed: 21890473
EMBO J. 2016 May 2;35(9):961-73
pubmed: 26912723
J Cell Biol. 2011 Jun 13;193(6):995-1007
pubmed: 21646402
Nat Struct Mol Biol. 2014 Oct;21(10):927-36
pubmed: 25218447
Mol Cell. 2010 Nov 12;40(3):353-63
pubmed: 21070963
Genes Dev. 2010 Jan 15;24(2):183-94
pubmed: 20080954
Bioessays. 2003 Feb;25(2):116-25
pubmed: 12539237
Science. 2013 Aug 23;341(6148):893-6
pubmed: 23907533
Nature. 2010 Sep 23;467(7314):479-83
pubmed: 20865002
Cold Spring Harb Perspect Biol. 2013 Sep 01;5(9):
pubmed: 23838438
PLoS Genet. 2011 Jun;7(6):e1002136
pubmed: 21698130
Cell Rep. 2014 Apr 10;7(1):53-61
pubmed: 24656819
Open Biol. 2014 Jan 08;4:130138
pubmed: 24403013
Nat Struct Mol Biol. 2018 Jul;25(7):631-640
pubmed: 29967540
Mol Biol Cell. 2017 Nov 1;28(22):2998-3012
pubmed: 28877985
Curr Biol. 2011 Dec 20;21(24):2055-63
pubmed: 22169533
Cell. 2010 Feb 5;140(3):349-59
pubmed: 20116089
Nature. 2018 Mar 8;555(7695):265-268
pubmed: 29489749
Oncogene. 2013 Jan 24;32(4):462-70
pubmed: 22370640
Genes Dev. 2018 Feb 1;32(3-4):224-229
pubmed: 29483155
Sci Signal. 2009 Aug 18;2(84):ra46
pubmed: 19690332
Mol Cell. 2015 Feb 5;57(3):492-505
pubmed: 25557548
Nat Commun. 2018 Nov 29;9(1):5061
pubmed: 30498216
Oncogene. 2008 Mar 20;27(13):1813-20
pubmed: 17906694
PLoS Comput Biol. 2010 May 13;6(5):e1000783
pubmed: 20485558
Annu Rev Pathol. 2015;10:425-48
pubmed: 25621662
Mol Cell. 2010 Jan 29;37(2):247-58
pubmed: 20122406
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7
pubmed: 18669648
J Biol Chem. 2006 Apr 14;281(15):10281-90
pubmed: 16446360
Cell Metab. 2012 Nov 7;16(5):672-83
pubmed: 23140645
Cell. 2005 Jun 17;121(6):887-98
pubmed: 15960976
Acta Crystallogr D Biol Crystallogr. 2015 Aug;71(Pt 8):1649-56
pubmed: 26249346
Cell Rep. 2016 Oct 4;17(2):556-569
pubmed: 27705801
Nature. 2018 Mar 1;555(7694):112-116
pubmed: 29466339
Mol Cell. 2014 Dec 4;56(5):681-95
pubmed: 25454945
Cell. 2011 Jul 8;146(1):80-91
pubmed: 21729781
Mol Cell Biol. 2006 Jul;26(13):4843-52
pubmed: 16782873
Nat Struct Mol Biol. 2013 Apr;20(4):412-8
pubmed: 23552296
Cell Rep. 2017 Mar 7;18(10):2508-2520
pubmed: 28273463
Cell Death Differ. 2011 Jul;18(7):1208-19
pubmed: 21274008
Science. 2013 May 24;340(6135):981-4
pubmed: 23704573
Cell Commun Signal. 2015 Feb 15;13:10
pubmed: 25885255

Auteurs

Pedro Ferreira (P)

Vertebrate DNA Replication Lab, Center of Medical Biotechnology, University of Duisburg-Essen, 45117, Essen, Germany.

Verena Höfer (V)

Vertebrate DNA Replication Lab, Center of Medical Biotechnology, University of Duisburg-Essen, 45117, Essen, Germany.

Nora Kronshage (N)

Vertebrate DNA Replication Lab, Center of Medical Biotechnology, University of Duisburg-Essen, 45117, Essen, Germany.

Anika Marko (A)

Vertebrate DNA Replication Lab, Center of Medical Biotechnology, University of Duisburg-Essen, 45117, Essen, Germany.

Karl-Uwe Reusswig (KU)

Max Planck Institute of Biochemistry, DNA Replication and Genome Integrity, 82152, Martinsried, Germany.

Bilal Tetik (B)

Vertebrate DNA Replication Lab, Center of Medical Biotechnology, University of Duisburg-Essen, 45117, Essen, Germany.

Christoph Dießel (C)

Vertebrate DNA Replication Lab, Center of Medical Biotechnology, University of Duisburg-Essen, 45117, Essen, Germany.

Kerstin Köhler (K)

Vertebrate DNA Replication Lab, Center of Medical Biotechnology, University of Duisburg-Essen, 45117, Essen, Germany.

Nikolai Tschernoster (N)

Cologne Center for Genomics (CCG), University of Cologne, Weyertal 115b, 50931, Cologne, Germany.
Institute of Human Genetics, University Clinics Cologne, Kerpener Strasse 34, 50931, Cologne, Germany.

Janine Altmüller (J)

Cologne Center for Genomics (CCG), University of Cologne, Weyertal 115b, 50931, Cologne, Germany.

Nina Schulze (N)

Imaging Center Campus Essen, Center of Medical Biotechnology, University of Duisburg-Essen, 45117, Essen, Germany.

Boris Pfander (B)

Max Planck Institute of Biochemistry, DNA Replication and Genome Integrity, 82152, Martinsried, Germany.

Dominik Boos (D)

Vertebrate DNA Replication Lab, Center of Medical Biotechnology, University of Duisburg-Essen, 45117, Essen, Germany. dominik.boos@uni-due.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH